Management of Ardhavbhedaka (Migraine) with Shirodhara and through Nasal Administration Procedure

Phase 3

Not yet recruiting

• Conditions: Migraine, unspecified. Ayurveda Condition: ARDHAVABEDAKAH,

• Registration Number: CTRI/2022/09/045891
• Lead Sponsor: Dr Sarvepalli Radhakrishnan Rajasthan Ayuved University Jodhpur

Brief Summary

*Ardhavabhedaka* isa disease that usually manifest in the half part of head.

In *Ayurveda Ardhavabhedaka* iscounted in 11 types of *Shirorogas.*According to differentAacharyas doshas involved in *Ardhavabhedaka*are:-

·         Sushruta-Sannipat i.e vata pitta kapha

·         Charaka  -Vata/ vata-kapha

·         Vagbhatta- Vata

 In Modern It can be wellcorrelated with “Migraineâ€. It is common neurovascular disease characterized byperiodic commonly throbbing , intense headache in one half of the head ,majority of times in the temporal region with some associated symptoms likenausea, vomiting, vertigo, photophobia etc. It is found in persons who areanxious, rigid, perfectionists and who work hard to fatigue themselves. In allopathyvarious drugs like NSAID’S Like acetaminophen, aspirin, ibuprofen, nauseamedicine, triptans, Ergotamine, CGRP receptor antagonists are being used tocounter the migraine. However some drugs are expensive  and producingseveral adverse effects like tingling, nausea, chest heaviness, fatigue,depression, insomnia, dizziness, weight gain, dry mouth etc. so we are lookingto alternative system especially *Ayurveda* and try to find out solution formigraine. *Ayurveda* plays  unique role in management of the disease.*Aacharya’s* explained that all the *Panchkarma* procedures are indicated for*Ardhavbhedaka*. However *Nasya* karma and *Shirodhara* plays a vital role indisintegrating the pathology of the disease. The study is open labelled parallel group trial to prove the efficacy of Gunja Taila Nasya and Dashmoola Shrit Ksheera Shirodhara in the management of *Ardhavabhedaka* (Migraine). In one group, 15 patients will be administered with Nasya and next 15 patients will be administered with Shirodhara.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-09-21
• Study Start: 2022-09-28

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• 1.Diagnosed and confirmed cases of ardhavabhedaka (migraine) according to CRF.
• 2.Clinically Fit for Nasya Karma and Shirodhara.
• 3.Patients willing to give written consent.

Exclusion Criteria

• 1.Patients who were suffering from secondary headaches like meningitis, brain tumor, encephalitis, cervical spondylitis, sinus, refractive errors & glaucoma.
• 2.Patients who were suffering from chronic disease like hypertension, COPD, renal disease etc.
• 3.Pregnant and lactating women.
• 4.A Patient of Ardhavbhedaka who was taking other treatment was excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual Analogue Score (Vas)	4 weeks
Midas (Migraine Disability Assessment Test)	4 weeks
Subjective Criteria Based On Symptoms Of Disease	4 weeks
Objective Criteria	4 weeks

Secondary Outcome Measures

Name	Time	Method
To find out the comperative efficacy of the treatment in both groups With the help of MIDAS (Migraine Disability Assessment Test),	VISUAL ANALOGUE SCORE (VAS) and Symptoms of Disease

Trial Locations

Locations (1)

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Hospital Of Ayurved; 🇮🇳 Jodhpur, RAJASTHAN, India

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Hospital Of Ayurved

🇮🇳Jodhpur, RAJASTHAN, India

Dr Madhu

Principal investigator

9050807620

madhu17beniwal@gmail.com